1 recruiting, 1 terminated. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Polyarticular Course Juvenile Idiopathic Arthritis: new trials by email Literature Review of Polyarticular Course Juvenile Idiopathic Arthritis trials Research Report on Polyarticular Course Juvenile Idiopathic Arthritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, Pharmacokinetics, and Efficacy of Filgotinib for the Treatment of Polyarticular-course Juvenile Idiopathic Arthritis in Children and Adolescents Filgotinib - Polyarticular Course Juvenile Idiopathic Arthritis | Phase 3 | Recruiting | Alfasigma S.p.A. | 65 | 2026-05-21 | 2026-06-12 |
| Efficacy and Safety Dose Finding Study of Givinostat to Treat Polyarticular Course Juvenile Idiopathic Arthritis Givinostat - Polyarticular Course Juvenile Idiopathic Arthritis | Phase 2 | Terminated | Italfarmaco | 16 | 2010-10-01 | 2014-04-16 |
Arthritis (2) · Autoimmune Diseases (2) · Connective Tissue Diseases (2) · Immune System Diseases (2) · Joint Diseases (2) · Musculoskeletal Diseases (2) · Rheumatic Diseases (2) · Skin and Connective Tissue Diseases (2)
GLPG0634 (1) · givinostat (1)
Alfasigma S.p.A. (1) · Italfarmaco (1)
Belgium (2) · Czechia (2) · Italy (2) · Spain (2) · France (1) · Germany (1) · Hungary (1) · Poland (1) · Romania (1) · Serbia (1) · Slovenia (1) · United Kingdom (1)
Catherine Vincent (1) · Francesco Zulian, MD (1)